Your browser doesn't support javascript.
Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort.
Huber, Meret K; Raichle, Claudia; Lingor, Paul; Synofzik, Matthis; Borgmann, Stefan; Erber, Johanna; Tometten, Lukas; Rimili, Wolfgang; Dolff, Sebastian; Wille, Kai; Knauss, Samuel; Piepel, Christiane; Lanznaster, Julia; Rieg, Siegbert; Prasser, Fabian; Pilgram, Lisa; Spottke, Annika; Klockgether, Thomas; Klein, Christine; Hopfner, Franziska; Höglinger, Günter U.
  • Huber MK; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Raichle C; Tropical Clinic Paul-Lechler Hospital, Tübingen, Germany.
  • Lingor P; Department of Neurology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Synofzik M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Borgmann S; Department of Neurodegenerative Diseases, Centre for Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Erber J; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
  • Tometten L; Department of Infectious Diseases and Infection Control, Hospital of Ingolstadt, Ingolstadt, Germany.
  • Rimili W; School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Dolff S; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Wille K; Department of Internal Medicine, Stiftung Kreuznacher Diakonie, Rhaunen, Germany.
  • Knauss S; Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Piepel C; University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, UKRUB, University of Bochum, Minden, Germany.
  • Lanznaster J; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Rieg S; Department of Hemato-Oncology and Infectious Diseases, Klinikum Bremen-Mitte, Bremen, Germany.
  • Prasser F; Department of Internal Medicine, Hospital Passau, Passau, Germany.
  • Pilgram L; Medical Center-University of Freiburg, Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Spottke A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Klockgether T; Department of Internal Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Klein C; German Center for Neurodegenerative Diseases, Bonn, Germany.
  • Hopfner F; Department of Neurology, University of Bonn, Bonn, Germany.
  • Höglinger GU; German Center for Neurodegenerative Diseases, Bonn, Germany.
Mov Disord ; 36(4): 791-793, 2021 04.
Article in English | MEDLINE | ID: covidwho-1103347
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neurodegenerative Diseases / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Mov Disord Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: Mds.28554

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Neurodegenerative Diseases / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Mov Disord Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: Mds.28554